Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients.
about
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseMicrobiome, Metabolome and Inflammatory Bowel DiseaseProtective and pro-inflammatory roles of intestinal bacteriaConsistent metagenomic biomarker detection via robust PCA.Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory miceMicrobial community and metabolomic comparison of irritable bowel syndrome faeces.Microbial 'old friends', immunoregulation and socioeconomic status.Accurate genome relative abundance estimation for closely related species in a metagenomic sampleEscherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityThe role of bacteria and pattern-recognition receptors in Crohn's disease.IBD-what role do Proteobacteria play?Chimpanzees and humans harbour compositionally similar gut enterotypesArtemisia supplementation differentially affects the mucosal and luminal ileal microbiota of diet-induced obese mice.Microbial dysbiosis in pediatric patients with Crohn's disease.Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel diseaseUnderstanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.Gut microbiome-host interactions in health and disease.Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.Role of the enteric microbiota in intestinal homeostasis and inflammationFecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.Symbiosis, dysbiosis, and rebiosis-the value of metaproteomics in human microbiome monitoring.Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycinAlterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acidCharacterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents.Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy.Gut-lung axis: The microbial contributions and clinical implications.Early Changes in Microbial Community Structure Are Associated with Sustained Remission After Nutritional Treatment of Pediatric Crohn's Disease.Fundamentals of microbial community resistance and resilience.Beyond the genome: community-level analysis of the microbial world.Next generation sequencing and a new era of medicine.The effects of intestinal microbial community structure on disease manifestation in IL-10-/- mice infected with Helicobacter hepaticus.Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease.Host-microbial Cross-talk in Inflammatory Bowel Disease.Epithelial calcineurin controls microbiota-dependent intestinal tumor development.Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis.
P2860
Q26741117-76FA6272-5803-4D73-9F0E-5D90E16610F8Q28078126-70085DBD-8430-4006-9CD9-2206CF049DE6Q28273923-FA4BA737-B649-4BFB-A4D5-A67759988A65Q30836964-B1B78486-F64C-4E30-AD06-C42371CC090CQ33741631-77EEBC2F-BF43-494B-9591-B342862A8DFDQ33823440-C848E5F1-A3C4-4F4E-AFA9-953900B40E0FQ33871387-F9AA4D02-CAE4-4E2A-94D4-16DDBE9B364FQ34037658-A8569422-C7F9-466B-A978-F557E7D1E275Q34048001-B470300E-6A2F-4A11-B3D9-F2035CD65DC7Q34163374-00C9DE68-EB2D-4532-ADDD-F3D81C1E14A5Q34255700-C8B793F6-24BC-485C-A442-20108B5D1A58Q34311515-8A810C81-2223-4C8F-A508-1B3A444E692CQ34339396-06F8D31F-3803-4CAC-B7DB-6712EFEE2F87Q34353528-21133D1E-DFFE-466F-80AC-F04E334DA536Q34637606-1DA83A73-8218-49CC-B26E-B2BA561BEEF1Q34775582-7357728D-3369-48FA-831B-B0C62C0863DBQ34786166-A145EF68-982E-49EE-81A0-8CACB3779757Q34971430-8E226B74-324A-4505-AF98-77D019C9C60FQ34976841-A78D46B0-FFD0-4FCE-B1AC-004945AF9153Q35024885-0E59D05C-5DC7-42C8-91FB-4D180FF3ADC8Q35052712-B9F525C0-E6C4-48DF-90BE-EB1976597A3EQ35114682-C034EBE8-75B2-487C-AF01-84DA9248B27DQ35328312-5AFA9F3C-8C03-4323-81A8-4E69A520942AQ35692976-99928BE6-2838-4AF0-A19F-90220E103752Q35742145-A1970CD3-11F2-47C5-AAD8-F6C481D6BAC4Q35954425-AB628E75-4D85-4394-9005-45064DAC0A7CQ36016002-4C0CE681-3EDB-4C22-881B-DC4FBAE53D61Q36063411-DC5EB684-B7CB-415C-BF6B-012E986B10CAQ36174406-B8343D28-E15A-43DD-A6D6-010916BD698DQ36180180-C66725C5-2419-4636-97C6-5CFC3ED42BEDQ36476972-B1545D81-580C-4DA0-BC75-19EF303E1E7BQ36648971-EC898A98-5B59-4E03-90A1-BD87B80E63D8Q37409165-4D5F53C0-2B5F-4891-86EF-A3B14E2C2461Q37677374-7987B98D-28C4-403E-A4A4-E0ECF35773D7Q37878446-058DCDAC-7390-4F3B-A91D-6EF7653D3BF4Q38661453-4B7BD5A5-0B8B-4143-AC58-218E043EA331Q39002865-B4485C7E-3D5C-4C65-8D10-6A7D97F156ECQ39162452-F7DFE18B-3C95-46C8-BC89-AA4406E3CCE0Q40818861-5D8A7389-9BEB-4F20-9F22-4E76644A5E20Q41036699-458DF612-8528-448D-941C-E4BB3ABEEDB2
P2860
Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transcriptional activity of th ...... matory bowel disease patients.
@ast
Transcriptional activity of th ...... matory bowel disease patients.
@en
type
label
Transcriptional activity of th ...... matory bowel disease patients.
@ast
Transcriptional activity of th ...... matory bowel disease patients.
@en
prefLabel
Transcriptional activity of th ...... matory bowel disease patients.
@ast
Transcriptional activity of th ...... matory bowel disease patients.
@en
P2093
P921
P356
P1476
Transcriptional activity of th ...... matory bowel disease patients.
@en
P2093
Andreas Nolte
Stefan Schreiber
Stephan Hellmig
Stephan J Ott
P304
P356
10.1099/JMM.0.021170-0
P577
2010-06-03T00:00:00Z